📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

MOESM3 of A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol... (2019)

First Author: Bradley J

Attributed to: MICA: BRONCH-UK a multicentre and multidisciplinary partnership grant tackling unmet needs in bronchiectasis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.6084/m9.figshare.11415381.v1

Publication URI: https://springernature.figshare.com/articles/journal_contribution/MOESM3_of_A_2_2_factorial_randomised_open-label_trial_to_determine_the_clinical_and_cost-effectiveness_of_hypertonic_saline_HTS_6_and_carbocisteine_for_airway_clearance_versus_usual_care_over_52_weeks_in_adults_with_bronchiectasis_a_protoco/11415381/1

Type: Journal Article/Review